Shilpa Medicare Secures European GMP Certification for Jadcherla Facility
Shilpa Medicare Ltd 路 Others (Uncategorized) 路 10 Oct 2026, 6:10 pm
Shilpa Medicare Secures European GMP Certification for Jadcherla Facility Shilpa Medicare announced on 10th Oct'26 that its Unit 4 facility in Jadcherla, Telangana, has received GMP certification from AGES, Austria, following an inspection conducted between 27th Jul'26 and 30th Jul'26. The certified unit is engaged in the manufacturing, testing, and distribution of sterile injections alongside non-sterile tablets and capsule finished dosage forms targeted for Europe and rest-of-the-world (RoW) markets.
Original exchange filing (PDF)
More announcements from Shilpa Medicare Ltd
- Q2FY27 Earnings Conference Call 05 November 2026 路 11 Nov 2026
- Audio link of the Investor Conference call for the quarter ended 30 September 2026. 路 06 Nov 2026
- Update on Corporate Insolvency Resolution Process of FTF Pharma Private Limited, a Wholly Owned Subsidiary of Shilpa Medicare Limited 路 05 Nov 2026
- Investor Presentation for the Quarter and Half year ended 30 September 2026 路 05 Nov 2026
- Outcome of the Board Meeting 路 05 Nov 2026
- Shilpa Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Financial Results for the Quarter and Half year ended 30 September 2026 路 05 Nov 2026
- SHILPA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
